Twist Bioscience Corporat... (TWST)
| Bid | 37.22 |
| Market Cap | 2.26B |
| Revenue (ttm) | 330.19M |
| Net Income (ttm) | -197.31M |
| EPS (ttm) | -3.38 |
| PE Ratio (ttm) | -11.19 |
| Forward PE | -25.6 |
| Analyst | Buy |
| Ask | 37.92 |
| Volume | 988,193 |
| Avg. Volume (20D) | 1,172,970 |
| Open | 38.56 |
| Previous Close | 38.32 |
| Day's Range | 36.83 - 38.51 |
| 52-Week Range | 30.73 - 60.90 |
| Beta | 2.34 |
About TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration ...
Analyst Forecast
According to 9 analyst ratings, the average rating for TWST stock is "Buy." The 12-month stock price forecast is $56, which is an increase of 48.03% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · seekingalpha.com
Twist Bioscience Corporation (TWST) Q1 2025 Earnings Call TranscriptTwist Bioscience Corporation (NASDAQ:TWST ) Q1 2025 Earnings Conference Call February 3, 2025 8:00 AM ET Company Participants Angela Bitting - Senior Vice President of Corporate Affairs Emily Leproust...